O Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul iniciou suas atividades em outubro de 1976. O HSL é um hospital geral, de natureza filantrópica, que assiste a pacientes adultos e pediátricos, abrangendo praticamente todas as especialidades médicas.

During the past decade, Hospital Sao Lucas - PUCRS conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 68 clinical trials were completed, i.e. on average, 72.3% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 32 clinical trials were completed. i.e. 71.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sao Lucas - PUCRS" #1 sponsor was "Hoffmann-La Roche" with 46 trials, followed by "Pfizer" with 12 trials sponsored, "Amgen" with 7 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sao Lucas - PUCRS" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 6 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sao Lucas - PUCRS" are "Breast Cancer" (11 trials), "Cardiovascular Diseases" (6 trials), "Non-small Cell Lung Cancer" (6 trials), "Non-Small Cell Lung Cancer" (5 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "Hospital Sao Lucas - PUCRS" in a lesser frequency.

Most popular intervention types in "Hospital Sao Lucas - PUCRS" are "Drug" (139 trials), "Biological" (16 trials), "Other" (14 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Atezolizumab" (14 trials), "Paclitaxel" (10 trials), "Carboplatin" (9 trials) and "Docetaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sao Lucas - PUCRS" are 141 trials for "All" genders, 11 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Sao Lucas - PUCRS". undefined are not yet recruiting, 26 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Hospital Sao Lucas - PUCRS, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sao Lucas - PUCRS, 8 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 8 trials that are defined as “Not Applicable".